Cetera Investment Advisers Bausch Health Companies Inc. Transaction History
Cetera Investment Advisers
- $45.9 Billion
- Q4 2024
A detailed history of Cetera Investment Advisers transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 11,462 shares of BHC stock, worth $82,067. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,462
Previous 12,718
9.88%
Holding current value
$82,067
Previous $103,000
10.68%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BHC
# of Institutions
271Shares Held
252MCall Options Held
5.12MPut Options Held
9.43M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$249 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$197 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$189 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$110 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$93.1 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.59B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...